Literature DB >> 1632457

Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.

J Hagège1, M N Peraldi, E Rondeau, C Adida, F Delarue, R Medcalf, W D Schleuning, J D Sraer.   

Abstract

Human mesangial cells secrete tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), the latter being secreted in large excess in vitro. We demonstrate that PAI-1 is a major component of the extracellular matrix of cultured human mesangial cells, where its deposition is dependent on cell density. By immunogold silver staining, epipolarization microscopy and dispersive X-ray spectrometry, we have shown that matrix-associated PAI-1 is synthesized by spreading human mesangial cells, as indicated by the time-dependent accumulation of PAI-1 and the inhibitory effect of cycloheximide. Furthermore, by in situ hybridization, PAI-1 mRNA was detected in cultured mesangial cells. t-PA is present inside the cells, or at the cell surface, but is never associated with the extracellular matrix. Exogenous t-PA can remove matrix-associated PAI-1 without affecting cell adhesion. A similar effect was obtained by addition of urokinase-type plasminogen activator (u-PA) but not with fibrinolysis unrelated enzymes. In conclusion, PAI-1 is synthesized by human cultured mesangial cells and is deposited in the extracellular matrix by nonconfluent cells, whereas less PAI-1 is seen between confluent cells. This can explain the absence of detectable PAI-1 in normal human kidney biopsies. t-PA released by mesangial cells can bind and detach matrix PAI-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632457      PMCID: PMC1886590     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  Cellular receptors for matrix proteins in normal human kidney and human mesangial cells.

Authors:  F G Cosio; D D Sedmak; N S Nahman
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

3.  Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.

Authors:  E M Salonen; A Vaheri; J Pöllänen; R Stephens; P Andreasen; M Mayer; K Danø; J Gailit; E Ruoslahti
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

4.  Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.

Authors:  W F Glass; R A Radnik; J A Garoni; J I Kreisberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.

Authors:  R J Johnson; H Iida; C E Alpers; M W Majesky; S M Schwartz; P Pritzi; K Gordon; A M Gown
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  Urokinase synthesis and binding by glomerular epithelial cells in culture.

Authors:  E Rondeau; S Ochi; R Lacave; C J He; R Medcalf; F Delarue; J D Sraer
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

7.  Synthesis of collagen and fibronectin by glomerular cells in culture.

Authors:  J M Foidart; J B Foidart; P R Mahieu
Journal:  Ren Physiol       Date:  1980

8.  Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.

Authors:  J Pöllänen; O Saksela; E M Salonen; P Andreasen; L Nielsen; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

9.  Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall.

Authors:  M G FARQUHAR; S L WISSIG; G E PALADE
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

Review 10.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.

Authors:  F Blasi; J D Vassalli; K Danø
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

View more
  3 in total

1.  Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

Authors:  T J de Vries; P H Quax; M Denijn; K N Verrijp; J H Verheijen; H W Verspaget; U H Weidle; D J Ruiter; G N van Muijen
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 2.  Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.

Authors:  M Yamamoto; R Sawaya; S Mohanam; V H Rao; J M Bruner; G L Nicolson; K Ohshima; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.

Authors:  Hideki Furuya; Yuka Sasaki; Runpu Chen; Rafael Peres; Kanani Hokutan; Kaoru Murakami; Nari Kim; Owen T M Chan; Ian Pagano; Lars Dyrskjøt; Jørgen B Jensen; Per-Uno Malmstrom; Ulrika Segersten; Yijun Sun; Abolfazl Arab; Hani Goodarzi; Steve Goodison; Charles J Rosser
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.